PHARM3R Trademark

Trademark Overview


On Friday, May 5, 2023, a trademark application was filed for PHARM3R with the United States Patent and Trademark Office. The USPTO has given the PHARM3R trademark a serial number of 97922131. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, September 11, 2024. This trademark is owned by Pharm3r LLC. The PHARM3R trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Market intelligence services; Statistical evaluations of marketing data in the nature of collecting and analyzing consumer data and statistics; Market research and market intelligence services in the nature of aggregating market research results, data and statistics for analyzing, understanding, reporting and predicting drug and medical device efficacy and reliability to impact patient outcomes; Market research and market intelligence services for supply chain information management; preparation of marketing reports, namely, creating reports for others based on third party data of post-market surveillance of drugs, medical devices, and patient outcomes

providing medical information, namely, providing reports for others based on third party data of post-market surveillance of drugs, medical devices, and patient outcomes
pharm3r

General Information


Serial Number97922131
Word MarkPHARM3R
Filing DateFriday, May 5, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, September 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements


Pseudo MarkFARMER
Goods and ServicesMarket intelligence services; Statistical evaluations of marketing data in the nature of collecting and analyzing consumer data and statistics; Market research and market intelligence services in the nature of aggregating market research results, data and statistics for analyzing, understanding, reporting and predicting drug and medical device efficacy and reliability to impact patient outcomes; Market research and market intelligence services for supply chain information management; preparation of marketing reports, namely, creating reports for others based on third party data of post-market surveillance of drugs, medical devices, and patient outcomes
Goods and Servicesproviding medical information, namely, providing reports for others based on third party data of post-market surveillance of drugs, medical devices, and patient outcomes

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSunday, June 4, 2023
Primary Code035
First Use Anywhere DateThursday, November 15, 2012
First Use In Commerce DateThursday, November 15, 2012

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 27, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharm3r LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10024

Trademark Events


Event DateEvent Description
Monday, February 5, 2024NON-FINAL ACTION WRITTEN
Tuesday, May 9, 2023NEW APPLICATION ENTERED
Sunday, June 4, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 31, 2024ASSIGNED TO EXAMINER
Monday, February 5, 2024NON-FINAL ACTION E-MAILED
Monday, February 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 27, 2024ASSIGNED TO LIE
Tuesday, September 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED